Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-18

Clinical Trial Update: Atropine 0.01% Eyedrops for Evolutive Myopia Treatment in Children

View source ↗

Summary

A clinical trial evaluating 0.01% atropine eye drops to slow myopia progression in children; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atropine 0.01% Eye Drops (atropine)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Myopia, Children | Status: RECRUITING